S
Souvik Sen
Researcher at University of South Carolina
Publications - 106
Citations - 7277
Souvik Sen is an academic researcher from University of South Carolina. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 30, co-authored 94 publications receiving 6230 citations. Previous affiliations of Souvik Sen include Seton Hall University & Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary: A report of the american college of cardiology foundation/american heart association task force on practice guidelines, american association for thoracic surgery, american college of radiology, american stroke association
Loren F. Hiratzka,George L. Bakris,Joshua A. Beckman,Robert M. Bersin,Vincent F. Carr,Donald E. Casey,Kim A. Eagle,Luke K. Hermann,Eric M. Isselbacher,Ella A. Kazerooni,Nicholas T. Kouchoukos,Bruce W. Lytle,Dianna M. Milewicz,David Reich,Souvik Sen,Julie A. Shinn,Lars G. Svensson,David M. Williams,Alice K. Jacobs,Sidney C. Smith,Jeffery L. Anderson,Cynthia D. Adams,Christopher E. Buller,Mark A. Creager,Steven M. Ettinger,Robert A. Guyton,Jonathan L. Halperin,Sharon A. Hunt,Harlan M. Krumholz,Frederick G. Kushner,Rick A. Nishimura,Richard L. Page,Barbara Riegel,William G. Stevenson,Lynn G. Tarkington,Clyde W. Yancy +35 more
Journal ArticleDOI
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Loren F. Hiratzka,George L. Bakris,Joshua A. Beckman,Robert M. Bersin,Vincent F. Carr,Donald E. Casey,Kim A. Eagle,Luke K. Hermann,Eric M. Isselbacher,Ella A. Kazerooni,Nicholas T. Kouchoukos,Bruce W. Lytle,Dianna M. Milewicz,David Reich,Souvik Sen,Julie A. Shinn,Lars G. Svensson,David M. Williams +17 more
TL;DR: It is essential that the medical profession play a central role in critically evaluating the evidence related to drugs, devices, and procedures for the detection, management, or prevention of disease.
Journal ArticleDOI
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Walter N. Kernan,Catherine M. Viscoli,Karen L. Furie,Lawrence H. Young,Silvio E. Inzucchi,Mark Gorman,Peter Guarino,Peter Guarino,Anne M. Lovejoy,Peter Peduzzi,Peter Peduzzi,Robin Conwit,Lawrence M. Brass,Gregory G. Schwartz,Harold P. Adams,L. Berger,Antonio Carolei,Wayne M. Clark,Bruce M. Coull,Gary A. Ford,Dawn Kleindorfer,J. R. O'Leary,Mark W Parsons,Peter A. Ringleb,Souvik Sen,J. D. Spence,David Tanne,David Z. Wang,T. R. Winder +28 more
TL;DR: In this trial involving patients without diabetes who had insulin resistance along with a recent history of ischemic stroke or TIA, the risk of stroke or myocardial infarction was lower among patients who received pioglitazone than among those who received placebo.
Journal ArticleDOI
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary
Loren F. Hiratzka,George L. Bakris,Joshua A. Beckman,Robert M. Bersin,Vincent F. Carr,Donald E. Casey,Kim A. Eagle,Luke K. Hermann,Eric M. Isselbacher,Ella A. Kazerooni,Nicholas T. Kouchoukos,Bruce W. Lytle,Dianna M. Milewicz,David Reich,Souvik Sen,Julie A. Shinn,Lars G. Svensson,David M. Williams +17 more
TL;DR: Alice K. Jacobs,MD, FACC, FAHA, Chair 2009–2011; Sidney C. Smith, Jr, MD, F ACC,FAHA, Immediate Past Chair 2006–2008; Jeffery L. Anderson, MD , Chair-Elect; Cynthia D. Adams, MSN, PhD, FAha.
Journal ArticleDOI
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
David C. Hess,Lawrence R. Wechsler,Wayne M. Clark,Sean I Savitz,Gary A. Ford,David Chiu,Dileep R. Yavagal,Ken Uchino,David S Liebeskind,Alexander P. Auchus,Souvik Sen,Cathy A. Sila,Jeffrey Vest,Robert W. Mays +13 more
TL;DR: Although no significant improvement was observed at 90 days in neurological outcomes with multipotent adult progenitor cells treatment, further clinical trials evaluating the efficacy of the intervention in an earlier time window after stroke are planned.